Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

Not Applicable

Recruiting

• Conditions: Anterior Glenoid Nerve Block; Pericapsular Nerve Group Block; Interscalene Brachial Plexus Block; Postoperative Pain; Shoulder Arthroscopic Surgeries

• Registration Number: NCT06765278
• Lead Sponsor: Ain Shams University

Brief Summary

This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

Detailed Description

Major surgeries of the shoulder constitute some of the most commonly performed orthopedic procedures. They often result in moderate to severe postoperative pain thereby requiring a multimodal analgesic approach centered around peripheral nerve blocks.

Postoperative pain management is the part of shoulder surgery to improve patient satisfaction, start rehabilitation process rapidly and decrease for hospital stay.

Interscalene blocks (ISB) are well-studied and established means of providing analgesia following shoulder surgery and are considered the gold standard mode of regional anesthesia and post-operative pain management in shoulder surgeries.

A novel technique: pericapsular nerve group (PENG) block can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. In addition, PENG block targets articular branches with less motor effect compared with interscalene brachial plexus block providing anesthetic and analgesic effect with less complication and better and sooner ambulation.

Study Timeline

• Study First Submitted: 2024-12-31
• Status Verified: 2025-01
• Study First Submitted QC: 2025-01-08
• Study First Posted: 2025-01-09
• Study Start: 2025-01-13
• Last Update Submitted: 2025-01-13
• Last Update Posted: 2025-01-14
• Primary Completion: 2025-06-01
• Study Completion: 2025-06-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• Age from 18 to 70 years.
• No sex predilection.
• American Society of Anesthesiology (ASA) physical status I-II.
• Undergoing shoulder arthroscopic surgeries.

Exclusion Criteria

• Patient's refusal.
• Patients with a history of drug allergies to study drugs.
• Evidence of local infection at the site of injection.
• Inability to cooperate
• Neuromuscular pathology (example: - Multiple Sclerosis)
• Previous trauma or surgery to the shoulder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Time to the 1st rescue analgesia	24 hours postoperatively	Time to the first request for the rescue analgesia (time from the end of surgery to the first dose of pethidine administrated).

Secondary Outcome Measures

Name	Time	Method
Total pethidine consumption	24 hours postoperatively	All patients will receive intravenous pethidine (30mg) on demand \[Visual Analogue Scale (VAS) score ≥3\].
Degree of pain	24 hours postoperatively	Degree of pain will be assessed using visual analogue scale (VAS). Each patient will be instructed about postoperative pain assessment with the VAS. VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed at 0, 6, 12, and 24 hours postoperatively.
Length of hospital stay	Till discharge from hospital (Up to one week).	Length of hospital stay will be recorded from admission till the discharge from hospital.
Time needed for the patient to freely move the operated limb	Postoperatively (Up to one week).	Time needed for the patient to freely move the operated limb will be recorded.
Degree of patients satisfaction	24 hours postoperatively	Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)

Trial Locations

Locations (1)

Ain Shams University; 🇪🇬 Cairo, Egypt